About Accellta
Accellta provides custom-made solutions for mass production of high quality human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine and research. Culturing is conducted in 3D suspension systems under feeder-free, adherent-free and xeno-free conditions. The tailored solutions dramatically reduce production time and costs.
 |
Read more |
Singles™
Pluripotent stem cells cultured as single-cells in suspension, providing enhanced uniformity and purity, serving as a platform for genetic manipulation.
Maxells™
Pluripotent stem cells cultured as aggregates in dynamic suspension devoid of feeder cell layer and/or microcarriers
Differentiation
Directed differentiation into neural cells is also an option after prolonged culture using aggregates in suspension technology
Xeno-Free Media
Accellta developed proprietary culture systems and formulations for animal product-free and serum-free culturing of pluripotent stem cells
News and Update
Top 100 Europe Winner
April 13, 2016, Amsterdam, Netherlands - Red Herring announced its Red Herring Europe award winners this evening at the Top 100 forum, recognizing Europe’s leading private companies and celebrating these startups’ innovations and technologies across their respective industries.
Atlas of Human Pluripotent Stem Cells
Editors: Michal Amit, Joseph Itskovitz-Eldor
Human pluripotent stem cells, including human embryonic stem cells and induced pluripotent stem cells, are a key focus of current biomedical research.
Ask Us About
Licensing & Collaboration Opportunities
Manufacturing Facility
Accellta operates a fully equipped top-tier manufacturing facility designed according to GMP guidelines for industrial manufacturing of cells. The facility includes over 550 sqm of clean room (88 sqm), QC laboratories, research laboratories and offices located at the Technion in Haifa, Israel.
Contact Us
Address:
Malat Building, Technion City, Haifa, Israel 3200004